Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Top Cited Papers
Open Access
- 31 August 2012
- journal article
- review article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 53 (9), 1723-1737
- https://doi.org/10.1194/jlr.R024794
Abstract
No abstract availableThis publication has 173 references indexed in Scilit:
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid LoadingCell Metabolism, 2011
- The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammationJournal of Hepatology, 2011
- The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-γ and Interfering with the Wnt/β-Catenin PathwaysOnline Journal of Public Health Informatics, 2010
- Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia*Published by Elsevier BV ,2010
- FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease StatesCell Metabolism, 2009
- TGR5-Mediated Bile Acid Sensing Controls Glucose HomeostasisCell Metabolism, 2009
- Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetesAtherosclerosis, 2009
- Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With MetforminArchives of Internal Medicine, 2008
- Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activationProceedings of the National Academy of Sciences of the United States of America, 2008
- Effects of FXR in foam-cell formation and atherosclerosis developmentBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006